The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document


Variant: NM_000329.3:c.825C>A

CA340745588

Gene: RPE65
Condition: RPE65-related recessive retinopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: 712bf686-0d03-4824-828c-16e06bf93992
Approved on: 2024-02-20
Published on: 2024-02-20

HGVS expressions

NM_000329.3:c.825C>A
NC_000001.11:g.68439224G>T
CM000663.2:g.68439224G>T
NC_000001.10:g.68904907G>T
CM000663.1:g.68904907G>T
NC_000001.9:g.68677495G>T
NG_008472.1:g.15736C>A
NG_008472.2:g.15736C>A
ENST00000262340.6:c.825C>A
ENST00000262340.5:c.825C>A
NM_000329.2:c.825C>A
More

Pathogenic

Met criteria codes 3
PVS1 PP4 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Leber Congenital Amaurosis/early onset Retinal Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPE65 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Leber Congenital Amaurosis/early onset Retinal Dystrophy VCEP
The NM_000329.3(RPE65):c.825C>A (p.Tyr275Ter) variant is a nonsense variant that introduces a premature stop codon into exon 8 of 14, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). At least one proband harboring this variant exhibits a phenotype including congenital night blindness (0.5 pts), extinguished rod ERG responses (0.5 pts), previous exome sequencing that did not provide an alternative explanation for visual impairment (2 pts), symptomatic onset between birth and age five years (1 pt), retinal degeneration with attenuated vessels (0.5 pts), and extinguished cone ERG responses (1 pt), which together are specific for RPE65-related recessive retinopathy (5.5 points, PMID: 31273949, PP4). In summary, this variant meets the criteria to be classified as pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: PVS1, PM2_Supporting, PP4. (VCEP specifications version 1.0.0; date of approval 09/21/2023).
Met criteria codes
PVS1
This is a nonsense variant that introduces a premature stop codon into exon 8 of 14, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1).
PP4
At least one proband harboring this variant exhibits a phenotype including congenital night blindness (0.5 pt), extinguished rod ERG responses (0.5 pt), previous exome sequencing that did not provide an alternative explanation for visual impairment (2 pt), symptomatic onset between birth and age five years (1 pt), retinal degeneration with attenuated vessels (0.5 pt), and extinguished cone ERG responses (1 pt), which together are specific for RPE65-related recessive retinopathy (5.5 points, PMID: 31273949, PP4).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.